0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chagas Disease Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-6V7253
Home | Market Reports | Health| Health Conditions
Global Chagas Disease Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Chagas Disease Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6V7253
Report
September 2024
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chagas Disease Treatment - Market Size

The global market for Chagas Disease Treatment was estimated to be worth US$ 581 million in 2023 and is forecast to a readjusted size of US$ 986 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030

Chagas Disease Treatment - Market

Chagas Disease Treatment - Market

This report focus on drugs for treating Chagas Disease. Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America, due to migration of people from Latin America to others countries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chagas Disease Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chagas Disease Treatment by region & country, by Type, and by Application.
The Chagas Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chagas Disease Treatment.
Market Segmentation

Scope of Chagas Disease Treatment - Market Report

Report Metric Details
Report Name Chagas Disease Treatment - Market
Forecasted market size in 2030 US$ 986 million
CAGR 7.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Benznidazole
  • Nifurtimox
Segment by Application
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A, Laboratorio Farmaceutico De Pernambuco, AstraZeneca, Daiichi Sankyo Company Ltd, Eisai Co Ltd, GlaxoSmithKline Plc, KaloBios Pharmaceuticals, Inc, Kancera AB, Novartis AG, Oblita Therapeutics BVBA, Sanofi Aventis, Grupo Praxis Pharmaceutical SA, Johnson & Johnson, ELEA SACIF Laboratory, F. Hoffmann-La Roche Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Chagas Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Chagas Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Chagas Disease Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Chagas Disease Treatment - Market size in 2030?

Ans: The Chagas Disease Treatment - Market size in 2030 will be US$ 986 million.

Who are the main players in the Chagas Disease Treatment - Market report?

Ans: The main players in the Chagas Disease Treatment - Market are Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A, Laboratorio Farmaceutico De Pernambuco, AstraZeneca, Daiichi Sankyo Company Ltd, Eisai Co Ltd, GlaxoSmithKline Plc, KaloBios Pharmaceuticals, Inc, Kancera AB, Novartis AG, Oblita Therapeutics BVBA, Sanofi Aventis, Grupo Praxis Pharmaceutical SA, Johnson & Johnson, ELEA SACIF Laboratory, F. Hoffmann-La Roche Ltd.

What are the Application segmentation covered in the Chagas Disease Treatment - Market report?

Ans: The Applications covered in the Chagas Disease Treatment - Market report are Hospitals, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Chagas Disease Treatment - Market report?

Ans: The Types covered in the Chagas Disease Treatment - Market report are Benznidazole, Nifurtimox

1 Market Overview
1.1 Chagas Disease Treatment Product Introduction
1.2 Global Chagas Disease Treatment Market Size Forecast
1.2.1 Global Chagas Disease Treatment Sales Value (2019-2030)
1.2.2 Global Chagas Disease Treatment Sales Volume (2019-2030)
1.2.3 Global Chagas Disease Treatment Sales Price (2019-2030)
1.3 Chagas Disease Treatment Market Trends & Drivers
1.3.1 Chagas Disease Treatment Industry Trends
1.3.2 Chagas Disease Treatment Market Drivers & Opportunity
1.3.3 Chagas Disease Treatment Market Challenges
1.3.4 Chagas Disease Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chagas Disease Treatment Players Revenue Ranking (2023)
2.2 Global Chagas Disease Treatment Revenue by Company (2019-2024)
2.3 Global Chagas Disease Treatment Players Sales Volume Ranking (2023)
2.4 Global Chagas Disease Treatment Sales Volume by Company Players (2019-2024)
2.5 Global Chagas Disease Treatment Average Price by Company (2019-2024)
2.6 Key Manufacturers Chagas Disease Treatment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Chagas Disease Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Chagas Disease Treatment
2.9 Chagas Disease Treatment Market Competitive Analysis
2.9.1 Chagas Disease Treatment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Chagas Disease Treatment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chagas Disease Treatment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Benznidazole
3.1.2 Nifurtimox
3.2 Global Chagas Disease Treatment Sales Value by Type
3.2.1 Global Chagas Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chagas Disease Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Chagas Disease Treatment Sales Value, by Type (%) (2019-2030)
3.3 Global Chagas Disease Treatment Sales Volume by Type
3.3.1 Global Chagas Disease Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Chagas Disease Treatment Sales Volume, by Type (2019-2030)
3.3.3 Global Chagas Disease Treatment Sales Volume, by Type (%) (2019-2030)
3.4 Global Chagas Disease Treatment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Chagas Disease Treatment Sales Value by Application
4.2.1 Global Chagas Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chagas Disease Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Chagas Disease Treatment Sales Value, by Application (%) (2019-2030)
4.3 Global Chagas Disease Treatment Sales Volume by Application
4.3.1 Global Chagas Disease Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Chagas Disease Treatment Sales Volume, by Application (2019-2030)
4.3.3 Global Chagas Disease Treatment Sales Volume, by Application (%) (2019-2030)
4.4 Global Chagas Disease Treatment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Chagas Disease Treatment Sales Value by Region
5.1.1 Global Chagas Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chagas Disease Treatment Sales Value by Region (2019-2024)
5.1.3 Global Chagas Disease Treatment Sales Value by Region (2025-2030)
5.1.4 Global Chagas Disease Treatment Sales Value by Region (%), (2019-2030)
5.2 Global Chagas Disease Treatment Sales Volume by Region
5.2.1 Global Chagas Disease Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Chagas Disease Treatment Sales Volume by Region (2019-2024)
5.2.3 Global Chagas Disease Treatment Sales Volume by Region (2025-2030)
5.2.4 Global Chagas Disease Treatment Sales Volume by Region (%), (2019-2030)
5.3 Global Chagas Disease Treatment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Chagas Disease Treatment Sales Value, 2019-2030
5.4.2 North America Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Chagas Disease Treatment Sales Value, 2019-2030
5.5.2 Europe Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Chagas Disease Treatment Sales Value, 2019-2030
5.6.2 Asia Pacific Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Chagas Disease Treatment Sales Value, 2019-2030
5.7.2 South America Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Chagas Disease Treatment Sales Value, 2019-2030
5.8.2 Middle East & Africa Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chagas Disease Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chagas Disease Treatment Sales Value
6.2.1 Key Countries/Regions Chagas Disease Treatment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Chagas Disease Treatment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Chagas Disease Treatment Sales Value, 2019-2030
6.3.2 United States Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chagas Disease Treatment Sales Value, 2019-2030
6.4.2 Europe Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chagas Disease Treatment Sales Value, 2019-2030
6.5.2 China Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chagas Disease Treatment Sales Value, 2019-2030
6.6.2 Japan Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chagas Disease Treatment Sales Value, 2019-2030
6.7.2 South Korea Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chagas Disease Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chagas Disease Treatment Sales Value, 2019-2030
6.9.2 India Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chagas Disease Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nortec Quimica SA
7.1.1 Nortec Quimica SA Company Information
7.1.2 Nortec Quimica SA Introduction and Business Overview
7.1.3 Nortec Quimica SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Nortec Quimica SA Chagas Disease Treatment Product Offerings
7.1.5 Nortec Quimica SA Recent Development
7.2 Bayer AG
7.2.1 Bayer AG Company Information
7.2.2 Bayer AG Introduction and Business Overview
7.2.3 Bayer AG Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bayer AG Chagas Disease Treatment Product Offerings
7.2.5 Bayer AG Recent Development
7.3 Laboratorio Elea Phoenix SA
7.3.1 Laboratorio Elea Phoenix SA Company Information
7.3.2 Laboratorio Elea Phoenix SA Introduction and Business Overview
7.3.3 Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Laboratorio Elea Phoenix SA Chagas Disease Treatment Product Offerings
7.3.5 Laboratorio Elea Phoenix SA Recent Development
7.4 Maprimed S.A
7.4.1 Maprimed S.A Company Information
7.4.2 Maprimed S.A Introduction and Business Overview
7.4.3 Maprimed S.A Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Maprimed S.A Chagas Disease Treatment Product Offerings
7.4.5 Maprimed S.A Recent Development
7.5 Laboratorio Farmaceutico De Pernambuco
7.5.1 Laboratorio Farmaceutico De Pernambuco Company Information
7.5.2 Laboratorio Farmaceutico De Pernambuco Introduction and Business Overview
7.5.3 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Product Offerings
7.5.5 Laboratorio Farmaceutico De Pernambuco Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Information
7.6.2 AstraZeneca Introduction and Business Overview
7.6.3 AstraZeneca Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 AstraZeneca Chagas Disease Treatment Product Offerings
7.6.5 AstraZeneca Recent Development
7.7 Daiichi Sankyo Company Ltd
7.7.1 Daiichi Sankyo Company Ltd Company Information
7.7.2 Daiichi Sankyo Company Ltd Introduction and Business Overview
7.7.3 Daiichi Sankyo Company Ltd Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Daiichi Sankyo Company Ltd Chagas Disease Treatment Product Offerings
7.7.5 Daiichi Sankyo Company Ltd Recent Development
7.8 Eisai Co Ltd
7.8.1 Eisai Co Ltd Company Information
7.8.2 Eisai Co Ltd Introduction and Business Overview
7.8.3 Eisai Co Ltd Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Eisai Co Ltd Chagas Disease Treatment Product Offerings
7.8.5 Eisai Co Ltd Recent Development
7.9 GlaxoSmithKline Plc
7.9.1 GlaxoSmithKline Plc Company Information
7.9.2 GlaxoSmithKline Plc Introduction and Business Overview
7.9.3 GlaxoSmithKline Plc Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 GlaxoSmithKline Plc Chagas Disease Treatment Product Offerings
7.9.5 GlaxoSmithKline Plc Recent Development
7.10 KaloBios Pharmaceuticals, Inc
7.10.1 KaloBios Pharmaceuticals, Inc Company Information
7.10.2 KaloBios Pharmaceuticals, Inc Introduction and Business Overview
7.10.3 KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Product Offerings
7.10.5 KaloBios Pharmaceuticals, Inc Recent Development
7.11 Kancera AB
7.11.1 Kancera AB Company Information
7.11.2 Kancera AB Introduction and Business Overview
7.11.3 Kancera AB Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Kancera AB Chagas Disease Treatment Product Offerings
7.11.5 Kancera AB Recent Development
7.12 Novartis AG
7.12.1 Novartis AG Company Information
7.12.2 Novartis AG Introduction and Business Overview
7.12.3 Novartis AG Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Novartis AG Chagas Disease Treatment Product Offerings
7.12.5 Novartis AG Recent Development
7.13 Oblita Therapeutics BVBA
7.13.1 Oblita Therapeutics BVBA Company Information
7.13.2 Oblita Therapeutics BVBA Introduction and Business Overview
7.13.3 Oblita Therapeutics BVBA Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Oblita Therapeutics BVBA Chagas Disease Treatment Product Offerings
7.13.5 Oblita Therapeutics BVBA Recent Development
7.14 Sanofi Aventis
7.14.1 Sanofi Aventis Company Information
7.14.2 Sanofi Aventis Introduction and Business Overview
7.14.3 Sanofi Aventis Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sanofi Aventis Chagas Disease Treatment Product Offerings
7.14.5 Sanofi Aventis Recent Development
7.15 Grupo Praxis Pharmaceutical SA
7.15.1 Grupo Praxis Pharmaceutical SA Company Information
7.15.2 Grupo Praxis Pharmaceutical SA Introduction and Business Overview
7.15.3 Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Product Offerings
7.15.5 Grupo Praxis Pharmaceutical SA Recent Development
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Company Information
7.16.2 Johnson & Johnson Introduction and Business Overview
7.16.3 Johnson & Johnson Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Johnson & Johnson Chagas Disease Treatment Product Offerings
7.16.5 Johnson & Johnson Recent Development
7.17 ELEA SACIF Laboratory
7.17.1 ELEA SACIF Laboratory Company Information
7.17.2 ELEA SACIF Laboratory Introduction and Business Overview
7.17.3 ELEA SACIF Laboratory Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.17.4 ELEA SACIF Laboratory Chagas Disease Treatment Product Offerings
7.17.5 ELEA SACIF Laboratory Recent Development
7.18 F. Hoffmann-La Roche Ltd.
7.18.1 F. Hoffmann-La Roche Ltd. Company Information
7.18.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
7.18.3 F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
7.18.4 F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Product Offerings
7.18.5 F. Hoffmann-La Roche Ltd. Recent Development
8 Industry Chain Analysis
8.1 Chagas Disease Treatment Industrial Chain
8.2 Chagas Disease Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chagas Disease Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Chagas Disease Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Chagas Disease Treatment Market Trends
    Table 2. Chagas Disease Treatment Market Drivers & Opportunity
    Table 3. Chagas Disease Treatment Market Challenges
    Table 4. Chagas Disease Treatment Market Restraints
    Table 5. Global Chagas Disease Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Chagas Disease Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Global Chagas Disease Treatment Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Chagas Disease Treatment Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Chagas Disease Treatment Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Chagas Disease Treatment Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Chagas Disease Treatment Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Chagas Disease Treatment
    Table 13. Global Chagas Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chagas Disease Treatment as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Chagas Disease Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Chagas Disease Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Chagas Disease Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Chagas Disease Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Chagas Disease Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Chagas Disease Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Chagas Disease Treatment Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Chagas Disease Treatment Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Chagas Disease Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Chagas Disease Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Chagas Disease Treatment Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Chagas Disease Treatment Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Chagas Disease Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Chagas Disease Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Chagas Disease Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Chagas Disease Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Chagas Disease Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Chagas Disease Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Chagas Disease Treatment Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Chagas Disease Treatment Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Chagas Disease Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Chagas Disease Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Chagas Disease Treatment Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Chagas Disease Treatment Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Chagas Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Chagas Disease Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Chagas Disease Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Chagas Disease Treatment Sales Value by Region (2019-2024) & (%)
    Table 44. Global Chagas Disease Treatment Sales Value by Region (2025-2030) & (%)
    Table 45. Global Chagas Disease Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Chagas Disease Treatment Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Chagas Disease Treatment Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Chagas Disease Treatment Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Chagas Disease Treatment Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Chagas Disease Treatment Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Chagas Disease Treatment Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Chagas Disease Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Chagas Disease Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Chagas Disease Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Chagas Disease Treatment Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Chagas Disease Treatment Sales Volume, (2025-2030) & (K Units)
    Table 57. Nortec Quimica SA Company Information
    Table 58. Nortec Quimica SA Introduction and Business Overview
    Table 59. Nortec Quimica SA Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Nortec Quimica SA Chagas Disease Treatment Product Offerings
    Table 61. Nortec Quimica SA Recent Development
    Table 62. Bayer AG Company Information
    Table 63. Bayer AG Introduction and Business Overview
    Table 64. Bayer AG Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Bayer AG Chagas Disease Treatment Product Offerings
    Table 66. Bayer AG Recent Development
    Table 67. Laboratorio Elea Phoenix SA Company Information
    Table 68. Laboratorio Elea Phoenix SA Introduction and Business Overview
    Table 69. Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Laboratorio Elea Phoenix SA Chagas Disease Treatment Product Offerings
    Table 71. Laboratorio Elea Phoenix SA Recent Development
    Table 72. Maprimed S.A Company Information
    Table 73. Maprimed S.A Introduction and Business Overview
    Table 74. Maprimed S.A Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Maprimed S.A Chagas Disease Treatment Product Offerings
    Table 76. Maprimed S.A Recent Development
    Table 77. Laboratorio Farmaceutico De Pernambuco Company Information
    Table 78. Laboratorio Farmaceutico De Pernambuco Introduction and Business Overview
    Table 79. Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Product Offerings
    Table 81. Laboratorio Farmaceutico De Pernambuco Recent Development
    Table 82. AstraZeneca Company Information
    Table 83. AstraZeneca Introduction and Business Overview
    Table 84. AstraZeneca Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. AstraZeneca Chagas Disease Treatment Product Offerings
    Table 86. AstraZeneca Recent Development
    Table 87. Daiichi Sankyo Company Ltd Company Information
    Table 88. Daiichi Sankyo Company Ltd Introduction and Business Overview
    Table 89. Daiichi Sankyo Company Ltd Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Daiichi Sankyo Company Ltd Chagas Disease Treatment Product Offerings
    Table 91. Daiichi Sankyo Company Ltd Recent Development
    Table 92. Eisai Co Ltd Company Information
    Table 93. Eisai Co Ltd Introduction and Business Overview
    Table 94. Eisai Co Ltd Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Eisai Co Ltd Chagas Disease Treatment Product Offerings
    Table 96. Eisai Co Ltd Recent Development
    Table 97. GlaxoSmithKline Plc Company Information
    Table 98. GlaxoSmithKline Plc Introduction and Business Overview
    Table 99. GlaxoSmithKline Plc Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. GlaxoSmithKline Plc Chagas Disease Treatment Product Offerings
    Table 101. GlaxoSmithKline Plc Recent Development
    Table 102. KaloBios Pharmaceuticals, Inc Company Information
    Table 103. KaloBios Pharmaceuticals, Inc Introduction and Business Overview
    Table 104. KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Product Offerings
    Table 106. KaloBios Pharmaceuticals, Inc Recent Development
    Table 107. Kancera AB Company Information
    Table 108. Kancera AB Introduction and Business Overview
    Table 109. Kancera AB Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Kancera AB Chagas Disease Treatment Product Offerings
    Table 111. Kancera AB Recent Development
    Table 112. Novartis AG Company Information
    Table 113. Novartis AG Introduction and Business Overview
    Table 114. Novartis AG Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Novartis AG Chagas Disease Treatment Product Offerings
    Table 116. Novartis AG Recent Development
    Table 117. Oblita Therapeutics BVBA Company Information
    Table 118. Oblita Therapeutics BVBA Introduction and Business Overview
    Table 119. Oblita Therapeutics BVBA Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Oblita Therapeutics BVBA Chagas Disease Treatment Product Offerings
    Table 121. Oblita Therapeutics BVBA Recent Development
    Table 122. Sanofi Aventis Company Information
    Table 123. Sanofi Aventis Introduction and Business Overview
    Table 124. Sanofi Aventis Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Sanofi Aventis Chagas Disease Treatment Product Offerings
    Table 126. Sanofi Aventis Recent Development
    Table 127. Grupo Praxis Pharmaceutical SA Company Information
    Table 128. Grupo Praxis Pharmaceutical SA Introduction and Business Overview
    Table 129. Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Product Offerings
    Table 131. Grupo Praxis Pharmaceutical SA Recent Development
    Table 132. Johnson & Johnson Company Information
    Table 133. Johnson & Johnson Introduction and Business Overview
    Table 134. Johnson & Johnson Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Johnson & Johnson Chagas Disease Treatment Product Offerings
    Table 136. Johnson & Johnson Recent Development
    Table 137. ELEA SACIF Laboratory Company Information
    Table 138. ELEA SACIF Laboratory Introduction and Business Overview
    Table 139. ELEA SACIF Laboratory Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. ELEA SACIF Laboratory Chagas Disease Treatment Product Offerings
    Table 141. ELEA SACIF Laboratory Recent Development
    Table 142. F. Hoffmann-La Roche Ltd. Company Information
    Table 143. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
    Table 144. F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Product Offerings
    Table 146. F. Hoffmann-La Roche Ltd. Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Chagas Disease Treatment Downstream Customers
    Table 150. Chagas Disease Treatment Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chagas Disease Treatment Product Picture
    Figure 2. Global Chagas Disease Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Chagas Disease Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Chagas Disease Treatment Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Chagas Disease Treatment Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Chagas Disease Treatment Report Years Considered
    Figure 7. Global Chagas Disease Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Chagas Disease Treatment Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chagas Disease Treatment Revenue in 2023
    Figure 10. Chagas Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Benznidazole Picture
    Figure 12. Nifurtimox Picture
    Figure 13. Global Chagas Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Chagas Disease Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Chagas Disease Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Chagas Disease Treatment Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Chagas Disease Treatment Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Retail Pharmacies
    Figure 20. Product Picture of Online Pharmacies
    Figure 21. Global Chagas Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Chagas Disease Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Chagas Disease Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Chagas Disease Treatment Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Chagas Disease Treatment Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Chagas Disease Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Chagas Disease Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Chagas Disease Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Chagas Disease Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Chagas Disease Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Chagas Disease Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Chagas Disease Treatment Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Chagas Disease Treatment Sales Volume (%), (2019-2030)
    Figure 38. United States Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Chagas Disease Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Chagas Disease Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Chagas Disease Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 59. Chagas Disease Treatment Industrial Chain
    Figure 60. Chagas Disease Treatment Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS